Product Name
Ornithine Carbamoyl Transferase (OCT), Recombinant Protein
Full Product Name
Recombinant Ornithine Carbamoyl Transferase (OCT)
Product Gene Name
OCT recombinant protein
[Similar Products]
Matching Pairs
Unconjugated
Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
Immunogen: Ornithine Carbamoyl Transferase (OCT) (MBS2009622)
Matching Pairs
APC-CY7 Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055853)
Immunogen: Ornithine Carbamoyl Transferase (OCT) (MBS2009622)
Matching Pairs
PE Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055854)
Immunogen: Ornithine Carbamoyl Transferase (OCT) (MBS2009622)
Matching Pairs
APC Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055855)
Immunogen: Ornithine Carbamoyl Transferase (OCT) (MBS2009622)
Matching Pairs
Cy3 Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055856)
Immunogen: Ornithine Carbamoyl Transferase (OCT) (MBS2009622)
Matching Pairs
FITC Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055857)
Immunogen: Ornithine Carbamoyl Transferase (OCT) (MBS2009622)
Matching Pairs
HRP Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055858)
Immunogen: Ornithine Carbamoyl Transferase (OCT) (MBS2009622)
Matching Pairs
Biotin Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2093380)
Immunogen: Ornithine Carbamoyl Transferase (OCT) (MBS2009622)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Sequence
The target protein is fused with two N-terminal Tags, His-tag and T7-tag, its sequence is listed below.
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEF-QGK SLGMIFEKRS TRTRLSTETG FALLGGHPCF LTTQDIHLGV NESLTDTARV LSSMADAVLA RVYKQSDLDT LAKEASIPII NGLSDLYHPI QILADYLTLQ EHYSSLKGLT LSWIGDGNNI LHSIMMSAAK FGMHLQAATP KGYEPDASVT KLAEQYAKEN GTKLLLTNDP LEAAHGGNVL ITDTWISMGQ EEEKKKRLQA FQGYQVTMKT AKVAASDWTF LHCLPRKPEE VDDEVFYSPR SLVFPEAENR KWTIMAVMVS LL
Chromosome Location
Chromosome: X; NC_000023.10 (38211736..38280703). Location: Xp21.1
3D Structure
ModBase 3D Structure for P00480
Purity/Purification
> 95%
Form/Format
Supplied as lyophilized form in PBS,pH7.4, containing 5% sucrose, 0.01% sarcosyl.
Organism
Homo sapiens (Human)
Expression System
Prokaryotic expression
Residues
Gln78~Leu342 (Accession # P00480) with two N-terminal Tags, His-tag and T7-tag
Subcellular Location
Mitochondrion matrix
Endotoxin Level
<1.0EU per 1ug (determined by the LAL method)
Predicted Isoelectric Point
6.4
Reconstitution
Reconstitute in sterile PBS, pH7.2-pH7.4.
Preparation and Storage
Avoid repeated freeze/thaw cycles. Store at 2-8 degree C for one month. Aliquot and store at -80 degree C for 12 months.
Stability Test: The thermal stability is described by the loss rate of the targetprotein. The loss rate was determined by accelerated thermal degradation test,that is, incubate the protein at 37 degree C for 48h, and no obvious degradation andprecipitation were observed. (Referring from China Biological Products Standard,which was calculated by the Arrhenius equation.) The loss of this protein is lessthan 5% within the expiration date under appropriate storage condition.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customera??s specifications, please inquire.
Other Notes
Small volumes of OCT recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
OCT recombinant protein
About the Marker: Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at doubleintensity to make location and size approximation of proteins of interestquick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
Applications Tested/Suitable for OCT recombinant protein
SDS-PAGE, Western Blot (WB), ELISA (EIA), Immunoprecipitation (IP)
SDS-Page of OCT recombinant protein
NCBI/Uniprot data below describe general gene information for OCT. It may not necessarily be applicable to this product.
NCBI Accession #
NP_000522.3
[Other Products]
NCBI GenBank Nucleotide #
NM_000531.5
[Other Products]
UniProt Primary Accession #
P00480
[Other Products]
UniProt Secondary Accession #
Q3KNR1; Q6B0I1; Q9NYJ5; A8K9P2; D3DWB0[Other Products]
UniProt Related Accession #
P00480[Other Products]
NCBI Official Full Name
ornithine carbamoyltransferase, mitochondrial
NCBI Official Synonym Full Names
ornithine carbamoyltransferase
NCBI Official Symbol
OTC??[Similar Products]
NCBI Official Synonym Symbols
OCTD
??[Similar Products]
NCBI Protein Information
ornithine carbamoyltransferase, mitochondrial; OTCase; ornithine transcarbamylase
UniProt Protein Name
Ornithine carbamoyltransferase, mitochondrial
UniProt Synonym Protein Names
Ornithine transcarbamylase
UniProt Gene Name
OTC??[Similar Products]
UniProt Synonym Gene Names
OTCase??[Similar Products]
UniProt Entry Name
OTC_HUMAN
NCBI Summary for OCT
This nuclear gene encodes a mitochondrial matrix enzyme. Missense, nonsense, and frameshift mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. Since the gene for this enzyme maps close to that for Duchenne muscular dystrophy, it may play a role in that disease also. [provided by RefSeq, Jul 2008]
UniProt Comments for OCT
OTC: Defects in OTC are the cause of ornithine carbamoyltransferase deficiency (OTCD). OTCD is an X- linked disorder of the urea cycle which causes a form of hyperammonemia. Mutations with no residual enzyme activity are always expressed in hemizygote males by a very severe neonatal hyperammonemic coma that generally proves to be fatal. Heterozygous females are either asymptomatic or express orotic aciduria spontaneously or after protein intake. The disorder is treatable with supplemental dietary arginine and low protein diet. The arbitrary classification of patients into the 'neonatal' group (clinical hyperammonemia in the first few days of life) and 'late' onset (clinical presentation after the neonatal period) has been used to differentiate severe from mild forms. Belongs to the ATCase/OTCase family.
Protein type: EC 2.1.3.3; Transferase; Amino Acid Metabolism - arginine and proline; Mitochondrial
Chromosomal Location of Human Ortholog: Xp21.1
Cellular Component: mitochondrion; mitochondrial matrix; mitochondrial inner membrane
Molecular Function: amino acid binding; ornithine carbamoyltransferase activity; phospholipid binding; phosphate binding
Biological Process: response to drug; citrulline biosynthetic process; response to zinc ion; midgut development; arginine biosynthetic process via ornithine; liver development; ornithine catabolic process; urea cycle; response to insulin stimulus
Disease: Ornithine Transcarbamylase Deficiency, Hyperammonemia Due To
Research Articles on OCT
1. carriers of the ornithine transcarbamylase (OTC) mutation are at risk for developing hyperammonemia coma during the postpartum period and at times of metabolic stress.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.